SG10202112104UA - Lactobacillus paracasei strain and use thereof - Google Patents

Lactobacillus paracasei strain and use thereof

Info

Publication number
SG10202112104UA
SG10202112104UA SG10202112104UA SG10202112104UA SG10202112104UA SG 10202112104U A SG10202112104U A SG 10202112104UA SG 10202112104U A SG10202112104U A SG 10202112104UA SG 10202112104U A SG10202112104U A SG 10202112104UA SG 10202112104U A SG10202112104U A SG 10202112104UA
Authority
SG
Singapore
Prior art keywords
lactobacillus paracasei
paracasei strain
strain
lactobacillus
paracasei
Prior art date
Application number
SG10202112104UA
Inventor
Gwang Pyo Ko
Woonki Kim
You-Jin Jang
Boram Seo
June-Chul Lee
Tae-Wook Nam
Insu Kim
Jin- Woo Lee
Original Assignee
Ko Biolabs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ko Biolabs Inc filed Critical Ko Biolabs Inc
Publication of SG10202112104UA publication Critical patent/SG10202112104UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/165Paracasei
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pediatric Medicine (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Packages (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10202112104UA 2018-05-09 2019-05-09 Lactobacillus paracasei strain and use thereof SG10202112104UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20180053279 2018-05-09

Publications (1)

Publication Number Publication Date
SG10202112104UA true SG10202112104UA (en) 2021-12-30

Family

ID=68468216

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11202010944RA SG11202010944RA (en) 2018-05-09 2019-05-09 Lactobacillus paracasei strain and use thereof
SG10202112104UA SG10202112104UA (en) 2018-05-09 2019-05-09 Lactobacillus paracasei strain and use thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11202010944RA SG11202010944RA (en) 2018-05-09 2019-05-09 Lactobacillus paracasei strain and use thereof

Country Status (13)

Country Link
US (2) US11291698B2 (en)
EP (1) EP3792342A4 (en)
JP (1) JP7121233B2 (en)
KR (4) KR102188020B1 (en)
CN (1) CN112534043B (en)
AU (1) AU2019265196B2 (en)
BR (1) BR112020022749A2 (en)
CA (1) CA3099668C (en)
MX (1) MX2020011916A (en)
MY (1) MY186993A (en)
PH (1) PH12020551878A1 (en)
SG (2) SG11202010944RA (en)
WO (1) WO2019216662A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112534043B (en) 2018-05-09 2024-04-26 Ko生物技术有限公司 Lactobacillus paracasei strain and application thereof
CN110893195B (en) * 2019-09-30 2023-03-14 内蒙古伊利实业集团股份有限公司 Lactobacillus paracasei ET-22 with function of relieving intestinal inflammation
JP7195714B2 (en) * 2020-10-19 2022-12-26 曽根ファーム株式会社 Composition for inflammatory bowel disease
CN110892940A (en) * 2019-11-20 2020-03-20 内蒙古伊利实业集团股份有限公司 New application of lactobacillus paracasei K56 in relieving intestinal inflammation
KR102330009B1 (en) * 2020-02-26 2021-11-23 경일대학교산학협력단 Lactobacillus paracasei JSKIU 12-9 (KCTC18805P) from fermented local food in Jeju and composition with the function of anti-aging, anti-cancer and anti-dental caries thereof
AU2021229110B2 (en) * 2020-02-26 2024-05-23 Gi Biome Lactobacillus Helveticus strain and composition containing same for prevention or treatment of inflammatory diseases
CN114032193B (en) * 2020-08-24 2022-06-07 汤臣倍健股份有限公司 Lactobacillus paracasei 207-27 and application thereof
KR20220026427A (en) * 2020-08-25 2022-03-04 단국대학교 천안캠퍼스 산학협력단 Composition of synbiotics for improving Irritable Bowel Syndrome comprising Opuntia humifusa extract and lactobacillus
CN114504599A (en) * 2020-11-16 2022-05-17 内蒙古伊利实业集团股份有限公司 New application of lactobacillus paracasei ET-22 in aspects of resisting aging and improving innate immunity
KR102268122B1 (en) * 2021-02-09 2021-06-22 주식회사 락토메이슨 A novel strain of lactobacillus paracasei lm1014 separated from kimchi, and composition for relieving premenstrual syndrome comprising the strain or its culture fluid
KR102294445B1 (en) * 2021-02-17 2021-08-27 주식회사 메디오젠 Infant and child origin lactic acid bacteria Lactobacillus paracasei MG4592 and composition comprising the lactic acid bacteria for enhancing intestine activity, anti-oxidant and anti-obesity
EP4070670A1 (en) * 2021-04-08 2022-10-12 University College Cork-National University of Ireland Cork Lacticaseibacillus paracasei em025-11 and uses thereof
KR102323673B1 (en) 2021-04-12 2021-11-08 주식회사 현대바이오랜드 Manufacturing method for HtrA(high temperature requirement A) chaperone probiotics and composition manufactured through thereof having the effect of controlling the intestinal microbiome for the treatment of inflammatory bowel disease
WO2022255553A1 (en) * 2021-06-03 2022-12-08 주식회사 엠디헬스케어 Composition for preventing or treating eye diseases comprising extracellular vesicles derived from lactobacillus paracasei
KR20230015688A (en) * 2021-07-23 2023-01-31 (주) 에이투젠 Novel Lactobacillus paracasei ATG-E1 strain, and composition comprising thereof for preventing or treating respiratory disease
CN113699063B (en) * 2021-08-10 2023-02-14 华南理工大学 Lactobacillus paracasei for reducing cholesterol and application thereof
CN113913346B (en) * 2021-11-22 2022-07-15 江南大学 Lactobacillus paracasei JN-1 and application thereof
CN114805474B (en) * 2022-04-02 2024-03-22 中国海洋大学 Lactobacillus casei FN345 and application thereof in preparation of bacterial agent for preventing diarrhea of infants in complementary feeding period
KR102582127B1 (en) * 2022-11-24 2023-09-25 힐링파머스 주식회사 Functional single ingredient composition reducing methane gas for carbon neutrality, improving cattle productivity and grade rate, and manufacturing method thereof
CN115517367B (en) * 2022-11-28 2023-05-05 广东益可维生物技术有限公司 Application of lactobacillus paracasei SMN-LBK in preparation of intestinal health promoting product

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE463796B (en) 1988-03-09 1991-01-28 Carl Erik Albertsson PROCEDURES FOR PREPARING A NUTRITIONAL COMPOSITION AND THEREFORE PREPARED NUTRITIONAL COMPOSITION
SE469875C (en) 1991-07-25 1997-04-14 Probi Ab Strain of intestinal colonizing Lactobacillus and composition for prophylaxis or treatment of gastrointestinal infections
IT1270216B (en) * 1994-06-14 1997-04-29 Recordati Chem Pharm METHOD OF STABILIZATION OF BIOLOGICALLY ACTIVE COMPOUNDS BY MICROGRANULES COVERED SUSPENDABLE IN FOOD FLUIDS
SE9501056D0 (en) 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
ID29150A (en) 1999-01-15 2001-08-02 Entpr Ireland Cs USE OF LACTOBACILLUS SALIVARIUS
KR100419132B1 (en) * 2000-12-29 2004-02-18 조성근 Lactobacillus paracasei subsp. paracasei CSK 01
KR100356672B1 (en) * 2001-12-27 2002-10-19 주식회사 바이로박트 Novel Lactobacillus sp. Strain And Using The Same
WO2007040446A1 (en) 2005-10-06 2007-04-12 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
KR100786364B1 (en) * 2006-06-23 2007-12-14 한국식품연구원 Novel strains of lactobacillus paracasei subsp. paracasei bfi46 and lactobacillus paracasei subsp. paracasei afj88 having immunoactivity
WO2009131208A1 (en) * 2008-04-25 2009-10-29 亀田製菓株式会社 Novel lactic acid bacterium having anti-allergic activity, anti-allergic agent, food and pharmaceutical composition each comprising the lactic acid bacterium, and process for production of the anti-allergic agent
CA2733249A1 (en) 2008-09-04 2010-03-11 Om Pharma Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
CN102168048B (en) * 2010-12-28 2012-08-08 黑龙江大学 Lactobacillus paracasei for high yield of L-lactic acid and fermentation method thereof
KR101810138B1 (en) * 2011-06-10 2017-12-19 (주)아모레퍼시픽 Composition comprising tea extract and lactic acid bacteria
CN103997899B (en) * 2011-06-20 2016-04-20 H.J.亨氏公司 Probiotic composition and method
EP2581461B1 (en) * 2011-10-14 2014-09-24 GenMont Biotech Incorporation Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases
ES2660813T3 (en) 2013-07-12 2018-03-26 Morinaga Milk Industry Co., Ltd. New lactic acid bacteria, drug, food product or drink, and I think they contain the new lactic acid bacteria
TWI505832B (en) * 2014-02-21 2015-11-01 Genmont Biotech Inc Lactobacillus strain, composition and use thereof for treating syndromes and related complications of autoimmune diseases
WO2015146916A1 (en) 2014-03-24 2015-10-01 大塚製薬株式会社 Novel lactobacillus paracasei strain
WO2015159124A1 (en) 2014-04-15 2015-10-22 Compagnie Gervais Danone Use of lactobacillus paracasei for promoting intestinal clearance of opportunistic pathogens after antibiotic dysbiosis
KR101644595B1 (en) * 2014-07-11 2016-08-03 한국식품연구원 Lactobacillus paracasei 1- 2- Composition for Preventing Improving or Treating of 1-mediated Immune Disease or 2-mediated Immune Disease Comprising Extracts from and Lactobacillus paracasei as an Active Ingredients
CN104894021B (en) * 2015-06-03 2018-02-09 宜兰食品工业股份有限公司 A kind of Lactobacillus paracasei and its application
NZ744342A (en) * 2016-01-19 2022-11-25 Symrise Ag Probiotics for use as anti-inflammatory agents in the oral cavity
CN107308190A (en) * 2017-07-04 2017-11-03 宇萃达生物科技(苏州)有限公司 Adjust the probiotic composition and its culture, preparation, purposes of human body microecological balance
CN112534043B (en) 2018-05-09 2024-04-26 Ko生物技术有限公司 Lactobacillus paracasei strain and application thereof
KR102098067B1 (en) * 2018-12-31 2020-04-07 주식회사 엠디헬스케어 Extracellular vesicle derived from Lactobacillus paracasei and use thereof
KR102254310B1 (en) * 2019-10-02 2021-05-21 주식회사 고바이오랩 Lactobacillus Acidophilus KBL409 and Use Thereof

Also Published As

Publication number Publication date
KR20200140224A (en) 2020-12-15
CN112534043B (en) 2024-04-26
JP2021522867A (en) 2021-09-02
KR20220024383A (en) 2022-03-03
WO2019216662A1 (en) 2019-11-14
MX2020011916A (en) 2021-04-13
PH12020551878A1 (en) 2021-05-31
AU2019265196A1 (en) 2020-11-26
KR102365414B1 (en) 2022-02-21
KR102188020B1 (en) 2020-12-07
US11992511B2 (en) 2024-05-28
US20210077550A1 (en) 2021-03-18
KR102448946B1 (en) 2022-09-30
JP7121233B2 (en) 2022-08-18
KR20200140225A (en) 2020-12-15
CA3099668C (en) 2023-10-03
MY186993A (en) 2021-08-26
CA3099668A1 (en) 2019-11-14
US20220175857A1 (en) 2022-06-09
CN112534043A (en) 2021-03-19
US11291698B2 (en) 2022-04-05
EP3792342A4 (en) 2022-01-12
BR112020022749A2 (en) 2021-03-02
AU2019265196B2 (en) 2022-06-16
SG11202010944RA (en) 2020-12-30
EP3792342A1 (en) 2021-03-17
KR102285958B1 (en) 2021-08-05
KR20190129014A (en) 2019-11-19

Similar Documents

Publication Publication Date Title
SG11202010944RA (en) Lactobacillus paracasei strain and use thereof
EP3747988A4 (en) Lactobacillus plantarum kbl396 strain and use thereof
EP3798298A4 (en) Lactobacillus gasseri kbl697 strain and use thereof
ZA202003788B (en) Composition based on probiotics and uses thereof
EP3865568A4 (en) Akkermansia muciniphila strain and use thereof
PL3412766T3 (en) Lactobacillus salivarius strain, composition comprising the same, and uses thereof
SG11202104315XA (en) Vesicles derived from lactobacillus paracasei and use of same
EP3798299A4 (en) Lactobacillus crispatus kbl693 strain and use thereof
DK3554517T3 (en) PROBIOTIC COMPOSITION COMPRISING LACTOBACILLUS RHAMNOSUS AND LACTOBACILLUS PARACASEI STRAINS
SG10201910740UA (en) Lactobacillus fermentum gkf3, composition comprising the strain and method for improving psychataxia using the same
EP3822338A4 (en) Lactobacillus paracasei et-22 and use thereof
IL281171A (en) Cellulose-synthase-like enzymes and uses thereof
EP3812452A4 (en) Bifidobacterium lactis bl-99 and application thereof
ZA202105312B (en) A genetically modified lactobacillus and uses thereof
SG11201607557WA (en) Novel lactobacillus paracasei strain
ZA201804863B (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
TWI559925B (en) Novel lactobacillus mali aps1 and use thereof
EP3601525C0 (en) Probiotic lactobacillus casei strain and its uses
LT3027734T (en) Isolated microorganism strain lactobacillus plantarum tak 59 ncimb42150 and its use
EP3620512A4 (en) Composition comprising lactobacillus plantarum cjlp475 strain and lactobacillus plantarum cjlp17 strain and use thereof
GB2568843B (en) Lactobacillus plantarum proliferator, and fermented product added with the proliferator and preparation method thereof
ZA202110015B (en) New pseudoxanthomonas beigongshangensis strain and use thereof
IL260181A (en) Compositions and methods of use of novel strains of lactobacillus fermentum
GB201713622D0 (en) Microbial strains and uses thereof
EP3620513A4 (en) Composition comprising lactobacillus plantarum cjlp475 and lactobacillus plantarum cjlp243 strains, and use thereof